Related Experiment Video
Updated: Jul 17, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Implications of Kidney Disease in Patients with Peripheral Arterial Disease and Vascular Calcification
Yogamaya Mantha1, Anum Asif1, Ayman Fath1
1Division of Cardiology, Department of Medicine, UT Health San Antonio, MC 7872, 8300 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.
Insights
Patients with chronic kidney disease (CKD) have a higher risk of peripheral artery disease (PAD), including critical limb ischemia (CLI). Vascular calcification is a key issue, and optimal revascularization treatments for CKD patients remain unproven.
Area of Science:
- Nephrology
- Vascular Biology
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) significantly elevates the risk of peripheral artery disease (PAD) compared to individuals with normal kidney function.
- PAD in CKD patients is marked by medial arterial calcification, intimal atherosclerosis, and calcification, driven by CKD-related metabolic derangements and inflammation.
- Vascular calcification (VC) affects over 80% of dialysis patients and 50% of CKD patients, leading to arterial stiffening and symptomatic PAD.
Purpose of the Study:
- To highlight the increased prevalence and severity of PAD in CKD patients.
- To underscore the role of vascular calcification in CKD-associated PAD and critical limb ischemia (CLI).
- To identify the lack of evidence-based guidelines for revascularization in this high-risk population.
Main Methods:
- Literature review focusing on the pathophysiology of PAD in CKD.
- Analysis of the prevalence and clinical impact of vascular calcification in CKD patients.
- Examination of current endovascular treatment options for severe calcific PAD.
Main Results:
- CKD patients exhibit a higher incidence of PAD and its severe manifestation, CLI.
- Hyperphosphatemia, hypercalcemia, elevated parathyroid hormone (PTH), inflammation, and oxidative stress are key drivers of VC in CKD.
- VC contributes significantly to arterial non-compliance and symptomatic PAD, increasing morbidity and mortality.
Conclusions:
- PAD and CLI pose substantial risks to CKD patients, largely due to prevalent vascular calcification.
- Current nonsurgical treatments for severe calcific PAD include angioplasty, atherectomy, and intravascular lithotripsy.
- There is a critical need for randomized controlled trials to establish optimal revascularization strategies for PAD and CLI in patients with CKD.
Abstract:
Persons with chronic kidney disease (CKD) are at a higher risk of developing peripheral artery disease (PAD) and its adverse health outcomes than individuals with normal renal function. Among patients with CKD, PAD is predominantly characterized by the calcification of the medial layer of arterial vessels in addition to intimal atherosclerosis and calcification. Vascular calcification (VC) is initiated by CKD-associated hyperphosphatemia, hypercalcemia, high concentrations of parathyroid hormone (PTH) as well as inflammation and oxidative stress. VC is widely prevalent in this cohort (>80% dialysis and 50% patients with CKD) and contributes to reduced arterial compliance and symptomatic peripheral arterial disease (PAD). The most severe form of PAD is critical limb ischemia (CLI) which has a substantial risk for increased morbidity and mortality. Percutaneous endovascular interventions with transluminal angioplasty, atherectomy, and intravascular lithotripsy are the current nonsurgical treatments for severe calcific plaque. Unfortunately, there are no randomized controlled trials that address the optimal approach to PAD and CLI revascularization in patients with CKD.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care

